You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

talazoparib

Showing 1 - 25 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)

Recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +2 more
Mar 14, 2022

Metastatic Castration-Resistant Prostate Cancer Trial (Talazoparib)

Available
  • Metastatic Castration-Resistant Prostate Cancer
  • Talazoparib
  • (no location specified)
Dec 6, 2022

Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial (Pidnarulex, Talazoparib)

Not yet recruiting
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jun 15, 2022

Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)

Recruiting
  • Metastatic Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Jul 18, 2022

Acute Myeloid Leukemia Trial in Stanford (Talazoparib, Topotecan, Gemcitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Talazoparib
  • +2 more
  • Stanford, California
    Stanford University
Jun 10, 2022

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Pittsburgh (ZEN003694, Talazoparib)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Apr 27, 2022

Metastatic or Unresectable Melanoma Trial in Cleveland (Nivolumab, Talazoparib)

Recruiting
  • Metastatic or Unresectable Melanoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Mar 22, 2022

Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +5 more
  • BET Bromodomain Inhibitor ZEN-3694
  • Talazoparib
  • (no location specified)
Aug 3, 2022

Tumors Trial in Changchun, Beijing (talazoparib)

Completed
  • Neoplasms
  • talazoparib
  • Changchun, Jilin, China
  • +1 more
Jan 12, 2022

Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Ovarian Carcinoma Trial in Ann Arbor

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Mar 31, 2022

US Talazoparib-Treated Locally Advanced or Metastatic Breast

Completed
  • Breast Cancer
  • Talazoparib
  • New York, New York
    Pfizer Inc
Nov 22, 2021

HRD 100 Gene Expression High, Triple Negative Breast Cancer Trial in Kuala Lumpur (Talazoparib)

Recruiting
  • HRD 100 Gene Expression High
  • Triple Negative Breast Cancer
  • Talazoparib
  • Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
    University Malaya Medical Centre
Mar 15, 2022

Breast Cancer Trial in Boston (Talazoparib, Sacituzumab Govitecan)

Recruiting
  • Breast Cancer
  • Talazoparib
  • Sacituzumab Govitecan
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Oct 25, 2021

Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2022

Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)

Recruiting
  • Recurrent Glioma
  • +4 more
  • Talazoparib
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Aug 19, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Brunswick,

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • New Brunswick, New Jersey
  • +2 more
Jun 28, 2022

Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Bethesda, Maryland
  • +1 more
Aug 16, 2022

Tumors, Breast Tumors Trial in Japan (talazoparib)

Active, not recruiting
Has Results
  • Neoplasms
  • Breast Neoplasms
  • talazoparib
  • Nagoya, Aichi, Japan
  • +7 more
Dec 20, 2021

TNBC - Triple-Negative Breast Cancer Trial in United States (Gedatolisib, Talazoparib)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Chicago, Illinois
  • +4 more
Jan 18, 2022

Advanced Refractory Solid Tumors, Advanced Triple Negative Breast Cancers, Metastatic Triple Negative Breast Cancers Trial in

Recruiting
  • Advanced Refractory Solid Tumors
  • +2 more
  • Singapore, Singapore
    National University Hospital
Aug 31, 2021

Metastatic Breast Cancer, Triple Negative Breast Cancer, Hormone Receptor Positive Tumor Trial in Indianapolis, Winston-Salem

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Indianapolis, Indiana
  • +1 more
Sep 28, 2021

Metastatic Renal Cell Carcinoma, Fumarate Hydratase Deficient Renal Cell Carcinoma, Succinate Dehydrogenase Deficient Renal Cell

Recruiting
  • Metastatic Renal Cell Carcinoma
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Dec 21, 2021

Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

Terminated
Has Results
  • Solid Tumor
  • +6 more
  • Birmingham, Alabama
  • +8 more
Feb 16, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022